Interactions between statins and the farnesoid-X-receptor inhibit positive effects of chenodeoxycholic acid on insulin secretion

被引：0

作者：

Hoffmeister, T. ^{[1
]}

Kaiser, J. ^{[2
]}

Drews, G. ^{[2
]}

Duefer, M. ^{[1
]}

机构：

[1] Inst Pharmaceut & Med Chem, Dept Pharmacol, Munster, Germany

[2] Inst Pharm, Dept Pharmacol & Clin Pharm, Tubingen, Germany

来源：

DIABETOLOGIA | 2018年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

398

引用

页码：S198 / S198

页数：1

共 50 条

[31] Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid
Pellicciari, R
Costantino, G
Camaioni, E
Sadeghpour, BM
Entrena, A
Willson, TM
Fiorucci, S
Clerici, C
Gioiello, A
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (18) : 4559 - 4569
[32] Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
Mueller, Michaela
Thorell, Anders
Claudel, Thierry
Jha, Pooja
Koefeler, Harald
Lackner, Carolin
Hoesel, Bastian
Fauler, Guenter
Stojakovic, Tatjana
Einarsson, Curt
Marschall, Hanns-Ulrich
Trauner, Michael
JOURNAL OF HEPATOLOGY, 2015, 62 (06) : 1398 - 1404
[33] Interactions between effects of adrenalectomy and diet on insulin secretion in fa/fa Zucker rats
Kibenge, MT
Chan, CB
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2001, 79 (01) : 1 - 7
[34] Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-κB Signaling, and Hepatic Inflammation
Gai, Zhibo
Visentin, Michele
Gui, Ting
Zhao, Lin
Thasler, Wolfgang E.
Haeusler, Stephanie
Hartling, Ivan
Cremonesi, Alessio
Hiller, Christian
Kullak-Ublick, Gerd A.
MOLECULAR PHARMACOLOGY, 2018, 94 (02) : 802 - 811
[35] Farnesoid X receptor-mediated carcinogenic effects of bile acid in esophageal cancer: A potential chemoprevention target
Guan, Baoxiang
Xu, Xiaochun
CANCER RESEARCH, 2010, 70
[36] Farnesoid X Receptor (FXR) Regulates Intestinal G Protein-Coupled Bile Acid Receptor 1 and Glucagon-Like Peptide 1 Secretion
Pathak, Preeti
Boehme, Shannon
Chiang, John Y.
GASTROENTEROLOGY, 2016, 150 (04) : S1151 - S1151
[37] Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor γ contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis (vol 315, pg 58, 2005)
Fiorucci, S.
Rizzo, G.
Antonelli, E.
Renga, B.
Mencarelli, A.
Riccardi, L.
Morelli, A.
Pruzanski, M.
Pellicciari, R.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (02): : 848 - 848
[38] Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action
Zhang, Jun
Kris-Etherton, Penny M.
Thompson, Jerry T.
Hannon, Daniel B.
Gillies, Peter J.
Vanden Heuvel, John P.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2012, 23 (04): : 400 - 409
[39] The Effects of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Patients With Chronic Diarrhea Secondary to Crohn's Ileal Disease
Nolan, Jonathan D.
Vassie, Claire
Johnston, Ian M.
Dew, Tracy
Shapiro, David
Walters, Julian R.
GASTROENTEROLOGY, 2014, 146 (05) : S797 - S797
[40] Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease
Marchiano, Silvia
Biagioli, Michele
Bordoni, Martina
Morretta, Elva
Di Giorgio, Cristina
Vellecco, Valentina
Roselli, Rosalinda
Bellini, Rachele
Massa, Carmen
Cari, Luigi
Urbani, Ginevra
Ricci, Patrizia
Monti, Maria Chiara
Giordano, Antonino
Brancaleone, Vincenzo
Bucci, Mariarosaria
Zampella, Angela
Distrutti, Eleonora
Cieri, Enrico
Cirino, Giuseppe
Fiorucci, Stefano
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (23):

← 1 2 3 4 5 →